The National Immunisation Schedule (NIS) is regularly reviewed to ensure it provides the best protection for the New Zealand community against vaccine preventable diseases. The review takes both the national and international situations into consideration.
From 1 July 2020, PCV10 (Pneumococcal vaccine) is moving to a 2 +1 schedule. This means the pneumococcal vaccine is not required at the 3-month immunisation event. A two-dose primary course will be given at ages 6 weeks and 5 months. The booster dose remains unchanged.
At the 3-month immunisation event, infants will be offered the DTaP-IPV-HepB/Hib (Infanrix-hexa) and RV1 (Rotarix) vaccines only.
Why has the 3-month PCV10 dose been removed?
The most up-to-date research has demonstrated that two doses of PCV10 in the first year of life, given at least 8 weeks apart followed by a booster dose in the second year of life, is as effective at protecting healthy children as a primary course of three doses and a booster.
For more information, see The Immunisation Advisory Centre website here.